BioSpace News Archive

Deals

WIRB-Copernicus Group (WCG) Acquires KMR Group and Metrics Champion Consortium (MCC)

The addition of KMR Group and MCC positions WCG’s Market Insights and Intelligence Division as the preeminent clinical trial benchmarking and research service in the industry.

July 25, 2018
·
3 min read
Drug Development

Tolero Pharmaceuticals Announces First Patient Dosed with Investigational Agent TP-0184, an Activin A Receptor Type 1 (ACVR1) Inhibitor, in Phase 1 Study of Patients with Advanced Solid Tumors

Tolero Pharmaceuticals, Inc. announced that the first patient has been dosed in a Phase 1 study evaluating investigational agent TP-0184

July 25, 2018
·
4 min read
Biotech Bay

Advanced Pharmaceutical Consultants, Inc. Supports Behavioral Health Facilities with Omnicell’s Secure Medication Management Technology

Automated Solutions Help Improve Medication Safety for Mental Health Patients Across the U.S. and its Territories

July 25, 2018
·
5 min read
Business

World’s first Center for Female Reproductive Longevity and Equality established at the Buck Institute

The Buck Institute for Research on Aging announced today that it is establishing the world’s first Center for Female Reproductive Longevity and Equality.

July 25, 2018
·
2 min read
Policy

Takara Bio granted manufacturing license from the Swedish Medical Product Agency for clinical-grade human embryonic stem cell line derivation and banking

Takara Bio announced that the Medical Products Agency granted a manufacturing license for derivation and banking of human embryonic stem (hES) cells to be produced under GMP conditions at the state-of-the-art laboratory located in Göteborg, Sweden, within Takara Bio Europe’s facility.

July 25, 2018
·
2 min read
Twelve Indiana communities join fight against Alzheimer’s disease during Alzheimer’s Association Walk to End Alzheimer’s® this fall

Participants raise critical awareness & funds for Alzheimer’s care, support, research

July 25, 2018
·
2 min read
Inversago Pharma Receives $7 Million in Series A Financing

Proceeds will support the development of new generations of cannabinoid-1 receptor inverse agonists for the treatment of several metabolic diseases including Prader-Willi Syndrome and type 1 diabetes.

July 25, 2018
·
4 min read
Drug Development

Takeda Announces Phase 3 Trial of ALUNBRIG® (brigatinib) Met Primary Endpoint Demonstrating Superiority in Progression-Free Survival Versus Crizotinib in Patients with ALK+ Advanced NSCLC Who are ALK Inhibitor Naïve

Takeda Pharmaceutical Company Limited today announced that the global, randomized, Phase 3 ALTA-1L trial met its primary endpoint at the first pre-specified interim analysis, with ALUNBRIG®.

July 25, 2018
·
14 min read
Business

Sinclair Research Appoints Scott Boley as Vice President of Toxicology

Sinclair Research has named Scott E. Boley, PhD, DABT, as vice president of toxicology.

July 25, 2018
·
2 min read
Biotech Beach

DexCom Announces Upcoming Conference Presentation---

DexCom, Inc. today announced that management will present an update on DexCom at the following upcoming investor conference.

July 25, 2018
·
1 min read